Tvardi Therapeutics
TVRD----
Tvardi Therapeutics (TVRD)
Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of novel, oral, and small molecule therapies targeting signal...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Tvardi Therapeutics Analyst Rating
View MoreForecast & Rating
Jul 8, 2026Price forecast
$9.75280.12%
Forecast & RatingBuy
9analysts
- Strong buy55.56%
- Buy22.22%
- Hold11.11%
- Sell0.00%
- Strong sell11.11%
News
- Tip Ranks · Jul 17 at 04:32 PM
Tvardi Therapeutics Expands At-The-Market Equity Program
- Global Report · Jul 17 at 04:11 AM
Power On: SkyWater’s Quantum Leap and Nakamoto’s Bitcoin Pivot
- benzinga_article · Jul 9 at 12:05 PM
12 Health Care Stocks Moving In Thursday's Intraday Session
- benzinga_article · Jul 9 at 08:06 AM
Why Is Tvardi Therapeutics Stock Falling Thursday?
- benzinga_article · Jul 8 at 04:05 PM
12 Health Care Stocks Moving In Wednesday's After-Market Session
- benzinga_article · Jul 8 at 12:05 PM
12 Health Care Stocks Moving In Wednesday's Intraday Session
